Hong, Zhongshi
Li, Yachen
Chen, Mingliang
Chen, Xiaojing
Deng, Xian
Wu, Yuze
Wang, Chunxiao
Qiu, Chengzhi
Funding for this research was provided by:
Fujian Provincial Traditional Chinese Medicine Science and Technology Program (2021zyyj73)
Natural Science Foundation of Fujian Province, China (2023J01734)
Science and Technology Project of Quanzhou (2022C027R)
Malignant Tumor Clinical Medicine Research Center (2020N090s)
Doctor Training Projects of The Second Affiliated Hospital of Fujian Medical University (2022BD1101-2022BD1107)
Key Clinical Specialty Discipline Construction Program of Fujian, P.R.C (WCZDZK202304, WCZDZK202305)
Article History
Received: 27 October 2023
Accepted: 13 May 2024
First Online: 28 May 2024
Declarations
:
: The methodologies employed in the present study were approved by the Ethics Committee of The Second Affiliated Hospital of Fujian Medical University (approval no. 2021336, Quanzhou, Fujian, China) including clinical sample collection and animal experiments. This study was conducted in accordance with the principles of the Declaration of Helsinki. All methods were performed in accordance with relevant guidelines and regulations. Informed consent was obtained from all the participants.
: Not applicable.
: The authors declare that they have no competing interests.